Early Observation and Mitigation of Challenges in Diabetes Management of COVID-19 Patients in Critical Care Units.
作者信息
Hamdy Osama, Gabbay Robert A
机构信息
Joslin Diabetes Center, Harvard Medical School, Boston, MA
Joslin Diabetes Center, Harvard Medical School, Boston, MA.
出版信息
Diabetes Care. 2020 Aug;43(8):e81-e82. doi: 10.2337/dc20-0944. Epub 2020 May 22.
Abstract
摘要
相似文献
1
Early Observation and Mitigation of Challenges in Diabetes Management of COVID-19 Patients in Critical Care Units.重症监护病房中 COVID-19 患者糖尿病管理挑战的早期观察与缓解
Diabetes Care. 2020 Aug;43(8):e81-e82. doi: 10.2337/dc20-0944. Epub 2020 May 22.
2
Prioritising action on diabetes during COVID-19.在2019冠状病毒病疫情期间优先采取糖尿病防治行动。
S Afr Med J. 2020 Jun 25;110(8):719-720.
3
Management of diabetes in patients with COVID-19.2019冠状病毒病患者的糖尿病管理
Lancet Diabetes Endocrinol. 2020 Aug;8(8):669. doi: 10.1016/S2213-8587(20)30235-7.
4
Management of diabetes in patients with COVID-19.2019冠状病毒病患者的糖尿病管理
Lancet Diabetes Endocrinol. 2020 Aug;8(8):668. doi: 10.1016/S2213-8587(20)30234-5.
5
Management of diabetes in patients with COVID-19.2019冠状病毒病患者的糖尿病管理
Lancet Diabetes Endocrinol. 2020 Aug;8(8):667-668. doi: 10.1016/S2213-8587(20)30227-8.
6
Management of diabetes in patients with COVID-19.2019冠状病毒病患者的糖尿病管理
Lancet Diabetes Endocrinol. 2020 Aug;8(8):666. doi: 10.1016/S2213-8587(20)30226-6.
7
Management of diabetes in patients with COVID-19.2019冠状病毒病患者的糖尿病管理
Lancet Diabetes Endocrinol. 2020 Aug;8(8):666-667. doi: 10.1016/S2213-8587(20)30231-X.
8
COVID-19 and diabetes: a co-conspiracy?2019冠状病毒病与糖尿病：一种共同的“阴谋”？
Lancet Diabetes Endocrinol. 2020 Oct;8(10):801. doi: 10.1016/S2213-8587(20)30315-6.
9
Severe SARS-CoV-2 infections: practical considerations and management strategy for intensivists.重症新型冠状病毒2型感染：重症监护医生的实际考量与管理策略
Intensive Care Med. 2020 Apr;46(4):579-582. doi: 10.1007/s00134-020-05967-x. Epub 2020 Feb 26.
10
Management of diabetes in patients with COVID-19 - Authors' reply.2019冠状病毒病患者的糖尿病管理——作者回复
Lancet Diabetes Endocrinol. 2020 Aug;8(8):669-670. doi: 10.1016/S2213-8587(20)30223-0.
引用本文的文献
1
Challenges in hyperglycemia management in critically ill patients with COVID-19.2019冠状病毒病危重症患者高血糖管理面临的挑战
World J Crit Care Med. 2022 Jul 9;11(4):219-227. doi: 10.5492/wjccm.v11.i4.219.
2
COVID-19 and diabetes: Association intensify risk factors for morbidity and mortality.新型冠状病毒肺炎（COVID-19）与糖尿病：关联性加剧发病和死亡风险因素。
Biomed Pharmacother. 2022 Jul;151:113089. doi: 10.1016/j.biopha.2022.113089. Epub 2022 May 8.
3
COVID-19 and Diabetes.2019冠状病毒病与糖尿病
J Clin Med. 2021 Nov 16;10(22):5341. doi: 10.3390/jcm10225341.
4
A Machine-Generated View of the Role of Blood Glucose Levels in the Severity of COVID-19.机器生成的视角：血糖水平在 COVID-19 严重程度中的作用。
Front Public Health. 2021 Jul 28;9:695139. doi: 10.3389/fpubh.2021.695139. eCollection 2021.
5
Management of Diabetes During a Dual Pandemic.双重疫情期间的糖尿病管理
J Nurse Pract. 2021 Jun;17(6):680-686. doi: 10.1016/j.nurpra.2020.12.021. Epub 2021 Feb 15.
6
The management of patients with coronavirus disease 2019 in intensive care unit (ICU) in low income countries: A review article.低收入国家重症监护病房（ICU）中2019冠状病毒病患者的管理：一篇综述文章。
Clin Nutr Open Sci. 2021 Jun;37:60-72. doi: 10.1016/j.nutos.2021.05.001. Epub 2021 May 23.
7
AFES A.S.-O.N.E.: ASEAN Survey Of Needs in Endocrinology in the Time of the COVID-19 Pandemic.AFES A.S.-O.N.E.：新冠疫情期间东盟内分泌学需求调查
J ASEAN Fed Endocr Soc. 2020;35(1):5-13. doi: 10.15605/jafes.035.01.10. Epub 2020 May 29.
8
Management of diabetes and hyperglycaemia in the hospital.医院中糖尿病和高血糖的管理。
Lancet Diabetes Endocrinol. 2021 Mar;9(3):174-188. doi: 10.1016/S2213-8587(20)30381-8. Epub 2021 Jan 27.
9
How to Best Protect People With Diabetes From the Impact of SARS-CoV-2: Report of the International COVID-19 and Diabetes Summit.如何最佳保护糖尿病患者免受SARS-CoV-2的影响：国际COVID-19与糖尿病峰会报告
J Diabetes Sci Technol. 2021 Mar;15(2):478-514. doi: 10.1177/1932296820978399. Epub 2021 Jan 21.
10
Differences in the Clinical and Hematological Characteristics of COVID-19 Patients with and without Type 2 Diabetes.COVID-19 患者中伴有和不伴有 2 型糖尿病的临床和血液学特征的差异。
J Diabetes Res. 2020 Dec 2;2020:1038585. doi: 10.1155/2020/1038585. eCollection 2020.
本文引用的文献
1
Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States.美国住院新冠病毒疾病（COVID-19）患者的血糖特征及临床结局
J Diabetes Sci Technol. 2020 Jul;14(4):813-821. doi: 10.1177/1932296820924469. Epub 2020 May 9.
2
Diabetic patients with COVID-19 infection are at higher risk of ICU admission and poor short-term outcome.感染 COVID-19 的糖尿病患者有更高的 ICU 入住风险和较差的短期预后。
J Clin Virol. 2020 Jun;127:104354. doi: 10.1016/j.jcv.2020.104354. Epub 2020 Apr 9.
3
The epidemiology, diagnosis and treatment of COVID-19.新型冠状病毒肺炎的流行病学、诊断与治疗。
Int J Antimicrob Agents. 2020 May;55(5):105955. doi: 10.1016/j.ijantimicag.2020.105955. Epub 2020 Mar 28.
4
Prevalence of Underlying Diseases in Hospitalized Patients with COVID-19: a Systematic Review and Meta-Analysis.新冠病毒肺炎住院患者基础疾病的患病率：一项系统评价与Meta分析
Arch Acad Emerg Med. 2020 Mar 24;8(1):e35. eCollection 2020.
5
On the use of corticosteroids for 2019-nCoV pneumonia.关于皮质类固醇在2019新型冠状病毒肺炎中的应用。
Lancet. 2020 Feb 29;395(10225):683-684. doi: 10.1016/S0140-6736(20)30361-5. Epub 2020 Feb 12.
6
Vitamin C Can Shorten the Length of Stay in the ICU: A Meta-Analysis.维生素 C 可缩短 ICU 住院时间：一项荟萃分析。
Nutrients. 2019 Mar 27;11(4):708. doi: 10.3390/nu11040708.
7
Diabetes Technology Update: Use of Insulin Pumps and Continuous Glucose Monitoring in the Hospital.糖尿病技术更新：医院中胰岛素泵和连续血糖监测的使用。
Diabetes Care. 2018 Aug;41(8):1579-1589. doi: 10.2337/dci18-0002. Epub 2018 Jun 23.
8
Continuous Glucose Monitor Interference With Commonly Prescribed Medications: A Pilot Study.持续葡萄糖监测仪与常用处方药之间的相互干扰：一项初步研究。
J Diabetes Sci Technol. 2017 Sep;11(5):936-941. doi: 10.1177/1932296817697329. Epub 2017 Mar 23.
9
Influence of Vitamin C and Maltose on the Accuracy of Three Models of Glucose Meters.维生素C和麦芽糖对三种血糖仪型号准确性的影响。
Ann Lab Med. 2016 May;36(3):271-4. doi: 10.3343/alm.2016.36.3.271.
10
Effect of acetaminophen on CGM glucose in an outpatient setting.对乙酰氨基酚在门诊环境中对连续血糖监测葡萄糖的影响。
Diabetes Care. 2015 Oct;38(10):e158-9. doi: 10.2337/dc15-1096. Epub 2015 Aug 12.
Zotero 插件